BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7042616)

  • 1. Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):96-101. PubMed ID: 7042616
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
    Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
    J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
    Dhople AM
    Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "proportional bactericidal test": a method for assessing bactericidal activity in drugs against Mycobacterium leprae in mice.
    Colston MJ; Hilson GR; Banerjee DK
    Lepr Rev; 1978 Mar; 49(1):7-15. PubMed ID: 347206
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapsone resistance in Mycobacterium leprae.
    Gillis TP; Williams DL
    Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of brodimoprim on Mycobacterium leprae in vitro and in mouse foot-pads.
    Dhople AM; Ortega I; Seydel JK; Gardner GD
    Indian J Lepr; 1990; 62(1):76-86. PubMed ID: 2193064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dormancy, drug resistance or dependency; some thoughts to ponder.
    Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
    Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM
    Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of desoxy fructo serotonin (DFS) on the multiplication of M. leprae in mouse foot-pad.
    Balakrishnan S; Mester L; Venkataramanaiah HN; Bhatia VN
    Lepr India; 1982 Jan; 54(1):56-8. PubMed ID: 7047899
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary dapsone resistance in Cebu, The Philippines; cause for concern.
    dela Cruz E; Cellona RV; Balagon MV; Villahermosa LG; Fajardo TT; Abalos RM; Tan EV; Walsh GP
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):253-6. PubMed ID: 8862258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of ATP assay for in vitro drug screening testing against human derived M. leprae.
    Katoch VM; Katoch K; Shivannavar CT; Sharma VD; Patil MA; Bharadwaj VP
    Indian J Lepr; 1989 Jul; 61(3):333-44. PubMed ID: 2671179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
    Sekar B; Elangeswaran N; Jayarama E; Rajendran M; Kumar SS; Vijayaraghavan R; Anandan D; Arunagiri K
    Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The infectivity of drug resistant cases.
    Desai AC; Apte SN; Bhide MB
    Lepr India; 1977 Jan; 49(1):54-8. PubMed ID: 330944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does dapsone resistance really matter in the MDT era?
    Ji B
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sensitivity to dapsone, sulfamethoxypyridazine and ethionamide of mycobacterium leprae taken from patients treated by the drugs].
    Pattyn SR; Rollier MT; Rollier R; Verdoolaeghe-Van Loo G
    Int J Lepr Other Mycobact Dis; 1975; 43(4):356-63. PubMed ID: 776843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further experience with the kinetic method for the study of drugs against Mycobacterium leprae in mice. Activities of DDS, DFD, ethionamide, capreomycin and PAM 1392.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1969; 37(4):389-97. PubMed ID: 4918202
    [No Abstract]   [Full Text] [Related]  

  • 19. Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.
    Gillis TP; Williams DL
    Indian J Lepr; 1999; 71(1):11-8. PubMed ID: 10439322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse foot pad technique for evaluation of drug resistance of M. leprae and other laboratory techniques to be used in leprosy control programmes.
    Pattyn SR
    Acta Leprol; 1983; 1(1):29-32. PubMed ID: 6401137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.